Bioscience - Lost in Translation?

Reviews / Votes

Advance Praise: It is not easy to keep up with the rapid pace of biomedical innovation nor changes in society and markets. This book captures exactly where we are right now: an unprecedented wave of innovation that arrives in health systems that are not prepared. And neither is the business model of the pharmaceutical industry. * Richard Bergstroem, Director, European Federation of Pharmaceutical Industry and Associations, Belgium * Advance Praise: This is a timely and provocative analysis. It is crucially important that researchers, clinicians, industry, and regulators adapt effectively to the new era of stratified medicine. This book is a welcome contribution to the debate. * Professor Jeremy Farrar, Executive Director, The Wellcome Trust, UK * Advance Praise: Richard Barker presents a provocative and thoughtful review of the health care ecosystem, demonstrating time and again that communication and collaboration across the stakeholder community are essential to realizing patient benefits from biomedical innovation. * Dr Barbara Lopez Kunz, Global Chief Executive, Drug Information Association, Switzerland * Advance Praise: Richard Barker, drawing on a quarter of a century of deep practical involvement in the topic, has written an invaluable synthesis of the factors that account for the disappointing rate of translation of science into affordable treatments to address unmet clinical need. Crucial will be forging of transparent productive relationships between academia, industry and an enlightened regulatory system. Essential reading for all those interested in making the medical innovation process faster, more productive and sustainable. * Professor Sir John Tooke, co-Chair of the Centre for the Advancement of Sustainable Medical Innovation, UK, former Vice-Provost of University College London * Advance Praise: Concisely frames the rich, dynamic environment for biologic/medical science with all the opportunities and challenges and offers orderly, thoughtful, practical approaches and solutions to facilitate and optimize medical innovation science. This book is suitable for both the knowledgeable scientific and the interested lay communities. * Dr Michael Friedman, Emeritus Chief Executive, City of Hope Cancer Center, Duarte, CA, USA and board member of life science companies * Advance Praise: This book provides an overview and in-depth analysis of medical science, drug development, etc., along with recommendations that are impressive. Amazing to say the least. * Mike Casey, board member and former Chief Executive of US biotech companies and former senior executive at Johnson & Johnson * Advance Praise: This is an important and timely book. Richard Barker comprehensively reviews current progress, but perhaps more importantly points out encouraging paths of translation as we move forward. In doing so, he provides a comprehensive scientific and socio-cultural rationale and basis for closing the collaboration gap, for bridging scientific advances, new product development and evaluation, and clinical care. * Stephen P. Spielberg, MD, PhD, former Dean, Dartmouth Medical School, Hannover, NH, USA, former Deputy Commissioner, US FDA, USA, and Editor-in-Chief, Therapeutic Innovation and Regulatory Science *